✦ LIBER ✦

Effect of cilostazol on optimized standard antiplatelet therapy in a patient with a cytochrome P450 2C19 2/2 genotype

✍ Scribed by Qiang Fu; Nobuaki Suzuki; Kaoru Takada; Hirosada Yamamoto; Shuichi Ishikawa; Naoyuki Yokoyama; Ken Kozuma; Takaaki Isshiki

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Cytochrome P450 2C

✍ Emily S. Reese; C. Daniel Mullins; Amber L. Beitelshees; Eberechukwu Onukwugha 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

Cost-Effectiveness of Cytochrome P450 2C

✍ Nermeen Madkour; Mark Bounthavong 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB

PCV74 ONE-YEAR COST-EFFECTIVENESS OF CYT

✍ SL Charland; B Agatep; D Malone; E Stanek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

335 Cytochrome P450 2C19*17 polymorphism

✍ U. Déry; E. Tourigny; M. Roy; P.L. Nadeau; M.E. Giguère; J. Rodés-Cabau; E. Laro 📂 Article 📅 2011 🏛 Pulsus Group Inc 🌐 English ⚖ 256 KB

Role of Omeprazole Dosage and Cytochrome

✍ Dr. Jyh-Chin Yang; Dr. Hong-Long Wang; Dr. Herng-Der Chern; Dr. Chia-Tung Shun; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

TCT-208: Elinogrel, A Novel Direct-actin

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Effect of cilostazol on optimized standard antiplatelet therapy in a patient with a cytochrome P450 2C19 *2/*2 genotype